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T here are estimated to be 1.5 million individuals with chronic hepatitis due to hepatitis B virus 
(HBV) or hepatitis C virus (HCV) in Japan,  including 
0.3 million latent patients who are unaware of their 
infection [1].  Chronic infection with hepatitis virus 
cannot be identified if the infected individual does not 
take a hepatitis screening test,  because hepatitis 
patients do not have disease-related symptoms.  In 
Japan,  a hepatitis screening test is usually offered at 
annual health check-ups in the workplace.  However,  
the participation rate is generally low,  because the test 
is not mandatory [2].  It is necessary to educate the 
public about the importance of taking a hepatitis 
screening test [3].
Fingertip blood sampling in mass examinations has 
been proposed for hepatitis screening because it does 
not require venous blood sampling by skilled medical 
staff,  and it enables blood collection without the uncer-
tainty of venous blood sampling in large-scale hepatitis 
screening tests outside the hospital.  The World Health 
Organization (WHO) guidelines on hepatitis B and C 
testing published in Feb.  2017 state that a fingertip 
blood sampling technique is available for both HBV and 
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We investigated whether a small amount of blood collected by fingertip blood sampling would be adequate in a 
mass examination for hepatitis virus infection in Japan.  A cross-sectional survey was conducted at health fairs 
in Kasaoka City and Shodoshima Island,  where participants took the hepatitis screening test.  A total of 114 
consecutive individuals who took the hepatitis screening test were enrolled.  Twenty microliters of plasma was 
successfully obtained from all participants.  Among the participants,  two had positive results for HBs antigen 
and two were positive for anti-HCV; all four were > 60 years old and rarely visited the hospital.  Thirty-three 
and 38 patients chronically infected with HBV and HCV,  respectively,  were examined for confirmatory assays 
at participating hospitals.  All subjects with undetectable serum levels of HBs antigen and anti-HCV had unde-
tectable levels of both markers in fingertip blood,  and the levels in serum and fingertip blood were significantly 
correlated (p< 0.01).  The lower detection limit of HBs antigen was defined as 0.005 IU/ml,  and the cut-off value 
of anti-HCV was 1.0 by using 10-μl fingertip blood samples.  The fingertip blood sampling described herein may 
be adequate in mass examinations for hepatitis virus testing in Japan.
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HCV serological assays [4],  and that the sensitivity and 
specificity of the use of whole blood samples by finger-
tip blood sampling compared to plasma or serum are 
high enough for the screenings.  In Japan,  however,  
fingertip blood sampling has not been used for hepatitis 
screening testing,  and comprehensive evaluations of the 
fingertip blood sampling technique in mass examina-
tions have not been performed according to our 
PubMed search.
We conducted the present study to validate the mea-
surements of HBs antigen and anti-HCV by fingertip 
blood sampling and to evaluate the efficiency of this 
sampling method in comparison with those by venous 
blood sampling in a mass examination for the screening 
of hepatitis virus infection.  Fingertip blood sampling 
would be an efficient strategy for providing individuals 
with opportunities to take a more convenient hepatitis 
screening test in the work place.
Methods
Study population. The cross-sectional survey was 
conducted among residents of Kasaoka City attending a 
health fair at a local healthcare center and among resi-
dents of Shodoshima Island attending a health fair at 
Shodoshima Central Hospital in November 2016.  The 
accuracy of the detection of HBs antigen and anti-HCV 
in fingertip blood was confirmed by the measurement 
of HBs antigen and anti-HCV in the fingertip blood and 
serum of patients with chronic HBV or HCV infection 
at the Departments of Gastroenterology of Okayama 
University Hospital and Kagawa Prefectural Hospital.  
The study was conducted in accordance with the 
Helsinki Declaration,  and was approved by the ethical 
committees of the participating institutes (#1611-014).  
All of the participants provided their written informed 
consent.
Specimen collection and hepatitis virus testing.
Whole blood samples by fingertip blood sampling and 
paired serum samples were simultaneously collected 
from the participants (Fig. 1).  For the preparation of 
fingertip blood samples,  the fingertips were punctured 
with a lancet (BD Microtainer Safety Lancet; Becton,  
Dickinson and Company,  Tokyo,  Japan).  Then,  60 μl 
of the whole blood collected was taken up by an 
EDTA-2K device designed for the collection of small 
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Fig.  1　 Fingertip blood sampling.  Round pieces of urethane tape with a central 4.5-mm hole A and the EDTA-2K blood-collecting device 
and container B were used for the ﬁngertip blood sampling (MBS,  Tokyo).  The ﬁngertip was sealed with a round piece of tape with a 4.5-
mm hole in the center and punctured with a lancet (BD Microtainer Safety Lancet; Becton,  Dickinson,  Tokyo).  Then,  60 μl of the whole 
blood was taken up by the EDTA-2K device C.
blood samples (MBS Corp.,  Tokyo,  Japan).  All of the 
samples were kept at 4°C during their transfer to our 
laboratory.
The plasma portions were separated by centrifuga-
tion,  and 10 μl of the separated plasma was diluted 
with 90 μl of diluent for the detection of HBs antigen 
and anti-HCV.  The detection of HBs antigen and anti-
HCV was done using a chemi-luminescence enzyme 
immunoassay with a blood analyzing instrument 
(HISCL HBsAg kit,  HISCL HCV Ab kit,  and HISCL-
800,  respectively,  Sysmex,  Kobe,  Japan) according to 
the manufacturer’s recommendations.  Based on the 
manufacturer’s specifications,  the lower quantitation 
limit of HBs antigen is 0.03 IU/ml and the cut-off value 
of anti-HCV is 1.0 in the assays using 100 μl of a serum 
sample.
Statistical analysis. We compared the results of 
the HBs antigen and anti-HCV measurements in fin-
gertip blood with those in the serum by determining the 
Pearson’s correlation coefficient.  The sensitivity,  speci-
ficity,  positive predictive value and negative predictive 
value of fingertip blood versus serum for HBs antigen 
and anti-HCV were calculated.  Statistical analyses were 
performed using JMP Pro ver.  12.0 software (SAS 
Institute,  Cary,  NC,  USA),  and p-values < 0.05 were 
considered significant.
Results
Characteristics of study participants. A total of 
114 consecutive individuals who took the hepatitis 
screening test were enrolled in the study: 98 residents 
of Kasaoka City and 16 residents of Shodoshima Island.  
Their mean age was 63 years,  ranging from 34 to 88  
years.  Among them,  86 individuals (75%) were female.  
In the second part of the study,  33 and 38 patients with 
chronic HBV and HCV infection,  respectively,  were 
enrolled at either of the 2 participating hospitals and 
underwent confirmatory assays for the measurement of 
HBs antigen and anti-HCV levels.  Whole blood sam-
ples were successfully collected from all of the partici-
pants by fingertip blood sampling using the novel col-
lection system with EDTA-2K.  Each sample consisted 
of 60 μl of blood and provided > 20 μl of plasma,  a suf-
ficient amount for each test.
Positive rates of HBs antigen and anti-HCV among 
the participants. Among the 98 residents of Kasaoka 
City who took the hepatitis virus test,  2 were positive 
for HBs antigen (a 61-year-old female and a 79-year-
old female),  and their levels of HBs antigen were nearly 
identical between their serum and fingertip blood.  Two 
other residents were positive for anti-HCV (a 68-year-
old female and a 78-year-old female) in both the serum 
and fingertip blood.  This was the first time that any of 
these four participants had taken a hepatitis virus test,  
and they did not have any other complications or liver 
disease-related symptoms.  The positivity rates were 
thus 2.0% for HBs antigen and 2.0% for anti-HCV.  
Among the 16 residents of Shodoshima Island who took 
the hepatitis virus test,  none showed positive results for 
HBs antigen or anti-HCV.
Accuracy of detection of HBs antigen in fingertip 
blood. All of the patients with HBs antigen 
> 0.03 IU/ml in the serum had detectable levels of HBs 
antigen in their fingertip blood samples (n=34; Fig.2A).  
Significant correlations were observed between the lev-
els of HBs antigen in the serum and those in the finger-
tip blood (R = 0.80,  p < 0.01).  One patient with less than 
the lower quantitation limit in the serum (0.02 IU/ml) 
had an undetectable level of HBs antigen in fingertip 
blood.  All 150 test participants who had undetectable 
HBs antigen in the serum also had undetectable HBs 
antigen in the fingertip blood samples.  These results 
showed that the sensitivity and specificity of detectable 
HBs antigen were 97.1% and 100%,  respectively.  The 
positive predictive value and negative predictive value 
were 100% and 99.3%,  respectively.  The lower detec-
tion limit of HBs antigen was defined as 0.005 IU/ml by 
using 10 μl of fingertip blood samples.
Accuracy of the detection of anti-HCV in fingertip 
blood. As shown in Fig. 2B,  all of the patients with 
anti-HCV > 1.0 in the serum also had detectable levels 
of anti-HCV in their fingertip blood (n = 40).  The anti-
HCV levels in the fingertip blood samples were signifi-
cantly correlated with those in the serum (R = 0.60,  
p < 0.01).  All of the 145 test participants with undetect-
able anti-HCV in the serum also had undetectable anti-
HCV in their fingertip blood samples.  These results 
showed that the sensitivity,  specificity,  positive predic-
tive value,  and negative predictive value were all 1.0.  
Three patients had anti-HCV levels between 1 and 10 in 
both their serum and fingertip blood.  These patients 
had undetectable HCV RNA in a further examination.  
The cut-off value of anti-HCV was defined as 1.0 by 
using 10 μl of fingertip blood samples.
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Discussion
This cross-sectional survey for a hepatitis screening 
test evaluated the use of a fingertip blood sampling 
technique in a mass examination for hepatitis virus 
infection in Japan,  by validating the measurement of 
HBs antigen and anti-HCV in the resulting samples 
from the mass examination.  The present study is the 
first to confirm that fingertip blood sampling would be 
useful in mass examinations for hepatitis virus infection 
in Japan.  Fingertip blood sampling removes the neces-
sity of venipuncture and would be adequate for the tests 
of HBs antigen and anti-HCV that are commercially 
available in Japan.
Previous investigations revealed that dried blood 
samples from fingertip blood sampling could be suc-
cessfully used for hepatitis screening tests [4 , 5].  We 
used the novel blood-collecting device described herein,  
which successfully and promptly collected a sufficient 
amount of whole blood by capillary action rather than 
aspiration,  without clotting or hemolysis,  from all of 
the participants.  The resulting samples were sufficient to 
detect HBs antigen and anti-HCV adequately.  In addi-
tion,  several participants volunteered to perform 
self-administered blood sampling under the close 
supervision of the medical staff,  and were successful in 
the self-administration.
In terms of the positive rates of HBs antigen and 
anti-HCV among the participants in Kasaoka City,  all 4 
individuals who had positive results of HBV or HCV 
were > 60 years of age,  and had no complications or 
liver disease-related symptoms.  These results suggested 
that hepatitis virus tests should be encouraged among 
elderly people in good health who rarely visit hospitals.  
The fingertip blood sampling technique in this study 
may become a versatile and efficient strategy for identi-
fying latent hepatitis patients.  Moreover,  the availabil-
ity of hepatitis screening by self-blood sampling from a 
fingertip under the close supervision of medical staff 
outside a hospital setting,  followed by consultation with 
a hepatologist as needed,  might increase the number of 
participants in hepatitis screenings in the future.
To assess the accuracy of the detection of HBs antigen 
and anti-HCV in the fingertip blood samples,  we com-
pared the quantities of HBs antigen and anti-HCV 
between the fingertip blood samples and paired serum 
samples.  In all of the participants with undetectable 
HBs antigen or anti-HCV in the serum,  HBs antigen or 
anti-HCV was also undetectable in fingertip blood sam-
ples,  and significant correlations of the values were 
observed between fingertip blood samples and the 
paired serum (p < 0.01).  The lower detection limit of 
HBs antigen was defined as 0.005 IU/ml and the cut-off 
value of anti-HCV was 1.0 by using 10 μl of fingertip 
blood samples,  which should be sufficient for hepatitis 
screening tests in clinical use.
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Fig. 2　 HBs antigen and anti-HCV results.  A scatter diagram of the measurement of HBs antigen levels in the ﬁngertip blood and paired 
serum samples is shown A,  along with a scatter diagram of the measurement of anti-HCV levels in the ﬁngertip blood and paired serum 
samples B.  The positive results of HBs antigen and anti-HCV are shown in the closed circle.
In conclusion,  fingertip blood sampling may be use-
ful in mass examinations in Japan.  A fingertip blood- 
sampling technique using a novel system permitted the 
collection of microliter-scale whole-blood samples,  
which should be adequate for the measurement of anti-
HCV and HBs antigen.
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